News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
3Win Corp. Executes Definitive Agreement to Acquire Serenus Global, Inc.
3Win Corp., a global wholesale distributor of CCELL vape products, announces the acquisition of Serenus Global, a multi-disciplinary controlled substances company, to expand into new markets. The acquisition is expected to close on December 12, 2023. For more information, visit www.3wincorp.com and www.serenusglobal.com -
COMMUNIQUÉ DE PRESSE
Expert Panel Provides Updated Data for Epilepsy and Pregnancy
The Epilepsy & Pregnancy Medical Consortium (EPMC) updates best practice recommendations for epilepsy patients considering pregnancy based on the groundbreaking MONEAD study, providing guidance on safe anti-seizure medications and breastfeeding -
COMMUNIQUÉ DE PRESSE
SpendMend Hires Bryan Olson as Western U.S. Area Vice President of Sales
SpendMend appoints Bryan Olson as Area Vice President of Sales for the Western United States. Olson brings decades of healthcare sales expertise from Stryker to drive platform sales and strengthen market presence -
-
COMMUNIQUÉ DE PRESSE
Cytonus Secures Series A Financing to Advance Pipeline of Novel Cargocyte(TM)-Based Medicines
Cytonus Therapeutics, Inc. secures $11.7 million Series A funding led by Partners Investment with a group of new investors to advance its pipeline of novel medicines enabled by its proprietary Cargocyte™ Drug Delivery Platform. The funds will be used for portfolio development targeting metastatic tumors and the central nervous system (CNS) -
